Literature DB >> 10660106

Changes in serum diamine oxidase activity during chemotherapy in patients with hematological malignancies.

T Tsujikawa1, K Uda, T Ihara, T Inoue, A Andoh, Y Fujiyama, T Bamba.   

Abstract

Serum diamine oxidase (DAO) activity is very low, but is considered to reflect quantitative changes in small intestinal mass. Therefore, we measured DAO activity during chemotherapy in patients with hematological malignancies in order to evaluate mucosal injury. DAO activity decreased from 1-3 weeks after chemotherapy but returned to initial levels after 4 weeks. As the dosage of anti-cancer drugs increased, DAO activity decreased more, but its activity was not related to other parameters. These findings suggest that serum DAO could be used as an indicator of mucosal injury during chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10660106     DOI: 10.1016/s0304-3835(99)00307-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Toward Oral Supplementation of Diamine Oxidase for the Treatment of Histamine Intolerance.

Authors:  Lucas Kettner; Ines Seitl; Lutz Fischer
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

2.  Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study.

Authors:  Yoshihiro Tanaka; Takao Takahashi; Kazuya Yamaguchi; Shinji Osada; Toshio Shimokawa; Kazuhiro Yoshida
Journal:  Support Care Cancer       Date:  2015-08-13       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.